First-in-Human Dose-escalation of GSK4425689A: Safety, Tolerability, and PK in Healthy Adults

GSK4425689A SCOngoingNot yet recruitingPhase 1Open NCT07646353 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…

NCT07646353 · Trial Tracker · ComplyRx